Tackling the global danger of drug-resistance: how far have we come?

AMR, commonly known as “drug resistance”, occurs when bugs such as bacteria, viruses and fungi become immune to medicines that once killed them or inhibited their growth. Resistance poses a serious threat to universal health coverage and the sustainable development goals, and is significantly accelerated by the increasing use of antimicrobial drugs such as antibiotics. The launch of the Indo-Pacific Centre for Health Security under the Department of Foreign Affairs and Trade (DFAT) has now made AU$300 million available for responding to nearby infectious disease threats, with antimicrobial resistance earmarked as a key concern. Read more

News Image

Lowy Institute


The Interpreter published by Lowy Institute